Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its boronic acid group enables it to participate in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds. This makes it valuable in the development of complex organic molecules, particularly in the creation of novel drug candidates targeting specific diseases. Additionally, its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting compounds, making it a preferred choice in medicinal chemistry for designing potent and selective drugs.